G. Knecht

发表

Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels

N. Ferreirós, P. Gute, J. Pfeilschifter, 2016, International journal of molecular sciences.

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

I. Grant, T. Harrer, D. Podzamczer, 2013 .

End‐stage renal disease and dialysis in HIV‐positive patients: observations from a long‐term cohort study with a follow‐up of 22 years

M. Bickel, P. Gute, E. Herrmann, 2013, HIV medicine.

Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus‐positive men who have sex with men in Germany

H. Stellbrink, A. Berger, M. Vogel, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Phylogenetic analysis ofacute hepatitis Cvirus genotype4 infections among human immunode¢ciency virus-positivemenwho have sexwith men inGermany

H. Stellbrink, A. Berger, M. Vogel, 2010 .

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers

M. Friedrich-Rust, P. Gute, E. Herrmann, 2012, BMC Gastroenterology.

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy

M. Bickel, A. Berger, H. Brodt, 2012, Medical Microbiology and Immmunology.

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.

M. Buti, T. Berg, A. Berger, 2017, Gastroenterology.

PEPDar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis

H. Jessen, P. Malfertheiner, T. Harrer, 2016, HIV medicine.

A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

M. Kurowski, S. Staszewski, P. Gute, 2006, British journal of clinical pharmacology.

Multiple hepatitis C virus (HCV) reinfections in HIV‐positive men who have sex with men: no influence of HCV genotype switch or interleukin‐28B genotype on spontaneous clearance

H. Stellbrink, J. Rockstroh, C. Boesecke, 2014, HIV medicine.

Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study

C. Boesecke, T. Kümmerle, I. Krznaric, 2018, Infection.

Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.

H. Brodt, P. Gute, E. Herrmann, 2015, Virology.

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy

M. Bickel, A. Berger, H. Brodt, 2013, Medical Microbiology and Immunology.

Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach.

O. Yang, Martha J. Lewis, D. Bhattacharya, 2013, Journal of virological methods.

Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.

M. Kurowski, S. Klauke, M. Bickel, 2009, The Journal of antimicrobial chemotherapy.

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.

F. Tacke, B. Paulweber, M. Muche, 2022, Journal of hepatology.

Pregnancy complications in HIV‐positive women: 11‐year data from the Frankfurt HIV Cohort

C. Königs, E. Herrmann, R. Linde, 2014, HIV medicine.

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years

N. Beerenwinkel, M. Bickel, P. Gute, 2023, JHEP reports : innovation in hepatology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV

I. Krznaric, C. Spinner, K. Schewe, 2018, Infection.

Drug Sensitivity of Currently Circulating Mpox Viruses.

M. Wass, S. Ciesek, M. Michaelis, 2022, The New England journal of medicine.

Evolution of Resistance Mutations during Low-Level Viral Replication in HIV-1–Infected Patients Treated with Zidovudine/Lamivudine/Abacavir as a First-Line Regimen

S. Staszewski, H. Doerr, M. Stürmer, 2007, Antiviral therapy.

Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis

M. Bickel, A. Berger, P. Gute, 2014, Medical Microbiology and Immunology.

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

E. Wolf, C. Stephan, H. Jaeger, 2010, European journal of medical research.

European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients

M. Buti, T. Berg, A. Schober, 2016 .

Comparison of Drug Resistance Scores for Tipranavir in Protease Inhibitor-Naïve Patients Infected with HIV-1 B and Non-B Subtypes

M. Bickel, H. Doerr, H. Brodt, 2011, Antimicrobial Agents and Chemotherapy.

M. Bickel, I. Krznaric, E. Wolf, 2018, HIV Medicine.

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.

M. Buti, A. Berger, U. Spengler, 2017, Gastroenterology.

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

M. Muche, K. Gadow, D. Semela, 2024, JHEP Reports.